The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped ...

Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a ...

Late Friday night, the Trump administration clawed back nearly $1 billion in spending approved by Congress, targeting several ...

Defenses against AI-created bioweapons will take years to build. We don’t have years to spare,” writes Ashish Jha.

Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of their own.

Our finding was remarkable because it had remained hidden within one of the best-studied organs in medical history.

President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.

At least five candidates are in the running to become the next director-general of the WHO, a job that will come with ...

With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of ...

We’ve come a long way since the fall of 2001, but we find ourselves with recent widening gaps in public health readiness and mitigation,” writes Daniel B. Jernigan.

The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and ...

Virtually all of the 175,000 public comments on a 2022 FDA proposal to ban menthol cigarettes were form letters, most echoing ...